Skip to main content
Prevest Denpro Limited logo

Prevest Denpro Limited — Investor Relations & Filings

Ticker · 543363 ISIN · INE0GAO01018 BSE.NS Manufacturing
Open in API
Filings indexed 10 across all filing types
Latest filing 2026-05-30 Regulatory Filings
Country IN India
Listing BSE.NS 543363

About Prevest Denpro Limited

https://www.prevestdenpro.com

Prevest Denpro Limited specializes in the research, development, and manufacturing of a comprehensive range of dental materials. The product portfolio includes restorative materials, endodontic solutions, luting cements, adhesives, and laboratory products. Key offerings encompass light-cure composites, glass ionomer cements, root canal sealers, and teeth whitening systems. The firm emphasizes innovation through its dedicated research and development wing, ensuring compliance with international quality standards such as ISO 13485 and CE certification. Serving a global clientele, the company provides solutions for clinical dentistry and laboratory applications, focusing on high-performance materials that enhance oral healthcare outcomes.

Recent filings

Filing Released Lang Actions
Non-Applicability of Annual Secretarial Compliance Report for the Financial year ended March 31, 2026
Regulatory Filings Classification · 90% confidence The document is an official letter to the stock exchange notifying a regulatory compliance matter—specifically the non-applicability of the Annual Secretarial Compliance Report under SEBI LODR regulations. It does not contain actual financial data, management changes, or results, nor does it announce publication of a report. This falls under general regulatory announcements and compliance filings, best classified as Regulatory Filings (RNS).
2026-05-30 English
This is to inform you that the Earnings conference call scheduled to be held on June 02, 2026 has been cancelled due to unforeseen circumstances.
Regulatory Filings Classification · 95% confidence The document is an intimation under SEBI (Listing Obligations and Disclosure Requirements) Regulations to BSE regarding the cancellation of a scheduled earnings conference call. It does not present financial data, is not a transcript or earnings release, nor a new report; rather it is a regulatory announcement/compliance filing. According to the category definitions, this fits best under Regulatory Filings (RNS).
2026-05-29 English
Intimation of Analyst / Institutional Investor Meeting to be held on, Tuesday, 02nd June 2026 at 4.00 PM.
Regulatory Filings Classification · 82% confidence The document is a letter to the stock exchange under SEBI LODR Regulation 30(6), notifying the schedule for an analyst/institutional investor earnings discussion conference call. It contains no financial data, no transcript, and is not the actual earnings release but an exchange filing to comply with listing obligations. It does not fit into any earnings release, report, or transcript category. It is a general regulatory announcement and therefore falls into the fallback category Regulatory Filings (RNS).
2026-05-27 English
The Company has appointed M/s. ADV & Associates, Chartered Accountants as Statutory Auditor of the Company for a period of 5 years, subject to approval of Members of the Company.
Regulatory Filings Classification · 95% confidence The document is an SEBI Listing Regulations disclosure to BSE announcing the board’s approval of appointments of the company’s secretarial, cost, internal and statutory auditors. It contains no financial statements or detailed report content, nor does it relate to board member or senior management changes, dividends, M&A, or earnings. It is an exchange filing under Regulation 30, making it a generic regulatory announcement. Therefore it best fits the Regulatory Filings category (RNS).
2026-05-27 English
The Company at its meeting held today i.e., May 27, 2026 has appointed Internal Auditor, Cost Auditor, Secretarial Auditor and Statutory Auditor of the Company.
Regulatory Filings Classification · 85% confidence The document is a letter to the stock exchange under SEBI Listing Regulation 30 announcing the Board’s approval of appointments of the internal auditor, cost auditor, secretarial auditor, and statutory auditor for the upcoming financial year. It contains no financial data, audit opinions, or full reports—just a regulatory intimation of auditor appointments. This does not fit into annual reports, earnings, M&A, board changes (which are only for directors/executives), or other specific categories, so it is best classified as a general regulatory announcement (fallback).
2026-05-27 English
The Company at its meeting held today i.e., May 27, 2026 has appointed Mr. Sukhen Pal Babuta as Additional Director (Non Executive Independent Director) of the Company.
Board/Management Information Classification · 95% confidence The document is an SEBI Listing Regulations intimation announcing the appointment of a new Non-Executive Independent Director to the Board, detailing board meeting timing and director profile. This is a management/board change announcement.
2026-05-27 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.